DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

GM-CSF in Treating Patients With Relapsed Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Biological: sargramostim

First Posted Date: 2009-05-25

Last Posted Date: 2013-08-23

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 17

Registration Number: NCT00908141

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507

Withdrawn

Conditions: Lung Cancer

First Posted Date: 2009-05-22

Last Posted Date: 2014-07-24

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT00907699

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Completed

Conditions: Psychosocial Effects of Cancer and Its Treatment
Cognitive/Functional Effects
Lung Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer

First Posted Date: 2009-05-20

Last Posted Date: 2015-09-30

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 80

Registration Number: NCT00905086

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Lapatinib Resistance in Patients With Breast Cancer

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-10-02

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT00898573

Locations: 🇺🇸
Geauga Regional Hospital, Cleveland, Ohio, United States
🇺🇸
Lake/University Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸
University Suburban Health Center, Cleveland, Ohio, United States

and more 6 locations

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Terminated

Conditions: Non-melanomatous Skin Cancer
Testicular Germ Cell Tumor
Pancreatic Cancer
Small Intestine Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-09-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 180

Registration Number: NCT00899132

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-10-02

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 60

Registration Number: NCT00900133

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss

Completed

Conditions: Cachexia
Pancreatic Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-09-30

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 44

Registration Number: NCT00899158

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

Withdrawn

Conditions: Metastatic Cancer
Lung Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-10-09

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT00897143

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants

Completed

Conditions: Precancerous Condition
Prostate Cancer

Interventions: Other: immunoenzyme technique
Other: laboratory biomarker analysis

First Posted Date: 2009-05-12

Last Posted Date: 2016-03-09

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT00898274

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
University Suburban Health Center, Cleveland, Ohio, United States
🇺🇸
UHHS Chagrin Highlands Medical Center, Cleveland, Ohio, United States

Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Methoxyamine
Drug: Temozolomide

First Posted Date: 2009-05-04

Last Posted Date: 2019-02-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 66

Registration Number: NCT00892385

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy